Department of Microbiology and Immunology, Translational Xenotransplantation Research Center, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
J Korean Med Sci. 2013 Dec;28(12):1723-8. doi: 10.3346/jkms.2013.28.12.1723. Epub 2013 Nov 26.
Constructing a bone marrow chimera prior to graft transplantation can induce donor-specific immune tolerance. Mixed chimerism containing hematopoietic cells of both recipient- and donor-origin has advantages attributed from low dose of total body irradiation. In this study, we explored the mechanism of mixed chimerism supplemented with depletion of Natural Killer cells. Mixed chimerism with C57BL/6 bone marrow cells was induced in recipient BALB/c mice which were given 450 cGy of γ-ray irradiation (n = 16). As revealed by reduced proliferation and cytokine production in mixed leukocyte reaction and ELISpot assay (24.6 vs 265.5), the allo-immune response to bone marrow donor was reduced. Furthermore, the induction of transferable immunological tolerance was confirmed by adoptive transfer and subsequent acceptance of C57BL/6 skin graft (n = 4). CD4(+)FoxP3(+) regulatory T cells were increased in the recipient compartment of the mixed chimera (19.2% → 33.8%). This suggests that regulatory T cells may be therapeutically used for the induction of graft-specific tolerance by mixed chimerism.
在移植前构建骨髓嵌合体可以诱导供体特异性免疫耐受。包含受者和供者来源造血细胞的混合嵌合体具有来自低剂量全身照射的优势。在这项研究中,我们探讨了补充自然杀伤细胞耗竭的混合嵌合体的机制。将 450cGyγ射线照射的 BALB/c 受体小鼠诱导产生 C57BL/6 骨髓细胞的混合嵌合体(n=16)。通过混合白细胞反应和 ELISpot 测定(24.6 对 265.5)显示增殖和细胞因子产生减少,对骨髓供体的同种免疫反应降低。此外,通过过继转移和随后接受 C57BL/6 皮肤移植(n=4)证实了可转移免疫耐受的诱导。混合嵌合体受体部分的 CD4+FoxP3+调节性 T 细胞增加(19.2%→33.8%)。这表明调节性 T 细胞可通过混合嵌合体用于诱导移植物特异性耐受的治疗。